New Chapter in the PCSK9 Book: Oral Inhibition of PCSK9 Binding to the LDL Receptor With a Macrocyclic Peptide

被引：1

作者：

Landmesser, Ulf ^{[1
,2
,3
,4
,5
]}

Makhmudova, Umidakhon ^{[1
,2
]}

机构：

[1] Deutsch Herzzentrum Charite, Dept Cardiol Angiol & Intens Med, Berlin, Germany

[2] Friede Springer Cardiovasc Prevent Ctr Charite, Berlin, Germany

[3] Partner Site Berlin, German Ctr Cardiovasc Res, Berlin, Germany

[4] Berlin Inst Hlth, Berlin, Germany

[5] Charite Univ Med Berlin, Hindenburgdamm 30, D-12203 Berlin, Germany

来源：

CIRCULATION | 2023年 / 148卷 / 02期

关键词：

Editorials; LDL cholesterol; PCSK9; PCKS9 oral inhibition;

D O I：

10.1161/CIRCULATIONAHA.123.065407

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：159 / 161

页数：3

共 50 条

[21] PCSK9
Abifadel, M.
Boileau, C.
ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
[22] Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor
Johns, Douglas G.
Campeau, Louis-Charles
Banka, Puja
Bautmans, An
Bueters, Tjerk
Bianchi, Elisabetta
Branca, Danila
Bulger, Paul G.
Crevecoeur, Inne
Ding, Fa-Xiang
Garbaccio, Robert M.
Guetschow, Erik D.
Guo, Yan
Ha, Sookhee N.
Johnston, Jennifer M.
Josien, Hubert
Kauh, Eunkyung A.
Koeplinger, Kenneth A.
Kuethe, Jeffrey T.
Lai, Eseng
Lanning, Christine L.
Lee, Anita Y. H.
Li, Li
Nair, Anilkumar G.
O'Neill, Edward A.
Stoch, S. Aubrey
Thaisrivongs, David A.
Tucker, Thomas J.
Vachal, Petr
van Dyck, Kristien
Vanhoutte, Frederic P.
Volckaert, Bram
Wolford, Dennis G.
Xu, Andy
Zhao, Tian
Zhou, Dan
Zhou, Susan
Zhu, Xiaohong
Zokian, Hratch J.
Walji, Abbas M.
Wood, Harold B.
CIRCULATION, 2023, 148 (02) : 144 - 158
[23] Beyond LDL Cholesterol, a New Role for PCSK9
Akram, Omar N.
Bernier, Adeline
Petrides, Francine
Wong, Gida
Lambert, Gilles
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (07) : 1279 - 1281
[24] Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly
Holla, Oystein L.
Cameron, Jamie
Berge, Knut Erik
Ranheim, Trine
Leren, Trond P.
BMC CELL BIOLOGY, 2007, 8 (1)
[25] A PCSK9 C-terminal Domain Binding Fab Inhibits PCSK9 Internalization and Restores LDL-uptake
Ni, Yan G.
Condra, Jon H.
Di Marco, Stefania
Orsatti, Laura
Shen, Xun
Pandit, Shilpa
Bottomley, Matthew J.
Ruggeri, Lionello
Cummings, Richard T.
Cubbon, Rose M.
Santoro, Joseph C.
Fisher, Timothy S.
Lo Surdo, Paola
Talamo, Fabio
Wood, Dana D.
Hammond, Holly A.
Wisniewski, Douglas
Volpari, Cinzia
Njimoluh, Leila
Ha, Sookhee
Hubbard, Brian
Carfi, Andrea
Sitlani, Ayesha
CIRCULATION, 2009, 120 (18) : S477 - S477
[26] Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly
Øystein L Holla
Jamie Cameron
Knut Erik Berge
Trine Ranheim
Trond P Leren
BMC Cell Biology, 8
[27] PCSK9-Hemmung – ein UpdateUpdate on PCSK9 inhibition
Julius L. Katzmann
Florian Custodis
Stephan H. Schirmer
Ulrich Laufs
Herz, 2022, 47 : 196 - 203
[28] LDL LOWERING EFFECT OF PCSK9 INHIBITION IS REDUCED IN WOMEN
Myasoedova, V.
Rimbert, A.
Camera, M.
Le May, C.
Capoulade, R.
Cariou, B.
Poggio, P.
ATHEROSCLEROSIS, 2023, 379
[29] Key aspects of PCSK9 inhibition beyond LDL lowering
Ramin-Mangata, Stephane
Blanchard, Valentin
Lambert, Gilles
CURRENT OPINION IN LIPIDOLOGY, 2018, 29 (06) : 454 - 459
[30] An Oral Antisense Oligonucleotide for PCSK9 Inhibition in Humans
Gennemark, Peter
Walter, Katrin
Clemmensen, Niclas
Rekic, Dinko
Nilsson, Catarina
Knoechel, Jane
Holtta, Mikko
Wang, Yanfeng
Yu, Rosie
Riney, Stanley
Monia, Brett P.
Andersson, Ulf
Jansson-Lofmark, Rasmus
Rocha, Cristina S.
Linden, Daniel
Ryden-Bergsten, Kristina
Hurt-Camejo, Eva
Crooke, Rosanne M.
Tillman, Lloyd
Carlsson, Bjorn
Elebring, Marie
Tivesten, Anna
Davies, Nigel
CIRCULATION, 2020, 142

← 1 2 3 4 5 →